Related Experiment Video
Updated: May 2, 2026

Author Spotlight: Decoding RNA Methylation's Role in Pancreatic Cancer - A Single-Base Resolution Study
Published on: July 7, 2023
TWIST1 hypermethylation is observed in pancreatic cancer
Manabu Sen-Yo1, Yutaka Suehiro2, Seiji Kaino1
1Departments of Gastroenterology and Hepatology and.
Abstract:
Despite the growing evidence demonstrating that TWIST1 is a noteworthy tumor biomarker, little is known about the clinical significance of TWIST1 methylation in human primary pancreatic cancer. In the present study, the association of TWIST1 methylation with clinicopathological characteristics was examined in human primary pancreatic cancer. Primary pancreatic cancer specimens and corresponding healthy pancreatic non-tumorous tissues from 33 patients with pancreatic cancer were used. Methylation levels of TWIST1 were compared with clinicopathological characteristics. The TWIST1 methylation level was higher in pancreatic cancer compared to corresponding non-neoplastic pancreatic tissues. The mean TWIST1 methylation was 66.7% for pancreatic cancer tissue and 15.0% for corresponding nonneoplastic pancreatic tissue (P=0.0004). These results suggested that TWIST1 methylation is a useful biomarker for the screening of pancreatic cancers. Studies using independent data sets are required to confirm these findings.
Related Concept Videos
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Induced Pluripotent Stem Cells
Somatic...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes
Cancers Originate from Somatic Mutations in a Single Cell

